◀ Back to GSK3B

GSK3B — HGF

Text-mined interactions from Literome

Liu et al., FASEB J 2002 : Pharmacological inhibitor studies demonstrated each pathway to be intimately involved in HGF induced increases in TER, cortical actin thickening, and phosphorylation of the Ser/Thr glycogen synthase kinase-3beta ( GSK-3beta ), a potential target for the HGF barrier promoting response
Lim et al., Cell Signal 2008 : Conversely, pharmacological inhibition of c-Met with its specific inhibitor, PHA-665752, or genetic knock-down of c-Met with short hairpin RNAs ( shRNAs ) suppressed HGF induced phosphorylation of Akt and GSK-3beta , increased phosphorylation of MAP2, and reduced dendrite number and length in cultured hippocampal neurons ... Inhibiting Akt activity with the phosphoinositide-3-kinase inhibitor LY294002 or Akt inhibitor X suppressed HGF induced phosphorylation of GSK-3beta , increased MAP2 phosphorylation, and blocked the ability of HGF to enhance dendritic length
Giannopoulou et al., Am J Pathol 2008 (Inflammation...) : HGF also induced renal GSK-3beta phosphorylation and inactivation after obstructive injury in vivo
Papkoff et al., Biochem Biophys Res Commun 1998 : WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells